Linear IgA/IgG bullous dermatosis after nivolumab therapy-Reference-Cited by-同舟云学术

Linear IgA/IgG bullous dermatosis after nivolumab therapy

Published:2021-04-26 Issue:8 Volume:60 Page:1007-1009
ISSN:0011-9059
Container-title:International Journal of Dermatology
language:en
Short-container-title:Int J Dermatol

Author:

Perandones‐González Héctor¹^ORCID,Alonso‐Alonso Teresa¹,Medina‐Valdivieso Soledad²,Linares‐Navarro Rubén¹,Sáez‐Álvarez Samuel³,Montanchez‐Mateo Judith⁴^ORCID

Affiliation:

1. Dermatology Department Complejo Asistencial Universitario de León Leon Spain

2. Oncology Department Complejo Asistencial Universitario de León Leon Spain

3. Pathology Department Complejo Asistencial Universitario de León Leon Spain

4. Immunology Department Complejo Asistencial Universitario de León Leon Spain

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijd.15627

Reference12 articles.

1. A Case of Nivolumab-Induced Bullous Pemphigoid: Review of Dermatologic Toxicity Associated with Programmed Cell Death Protein-1/Programmed Death Ligand-1 Inhibitors and Recommendations for Diagnosis and Management

2. Bullous disorders associated with anti–PD-1 and anti–PD-L1 therapy: A retrospective analysis evaluating the clinical and histopathologic features, frequency, and impact on cancer therapy

3. Linear IgA Disease of the Gingiva Following Nivolumab Therapy

4. Drug-induced linear IgA bullous dermatosis: Report of six cases and review of the literature

5. Linear IgA dermatosis with IgA and IgG autoantibodies to the 180 kDa bullous pemphigoid antigen (BP180): evidence for a distinct subtype

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Arzneimittelexantheme unter Immun- und zielgerichteter onkologischer Therapie;Die Dermatologie;2024-05-21

2. Immune checkpoint inhibitor-induced cutaneous toxicities: a review of histopathologic and clinical features;Human Pathology;2023-10

3. Nivolumab;Reactions Weekly;2021-08